Drug intelligence / Profile preview

xueshuantong injection

Development stage
Phase 4
Lead developer
Guangxi Wuzhou Pharmaceutical (Group)
Administration
Intravenous, Intramuscular
01

Overview

Xueshuantong Injection is a Traditional Chinese Medicine (TCM) preparation composed of the total saponins extracted from *Panax notoginseng* (Burk.) F.H. Chen. It is primarily indicated for the treatment of cardiovascular and cerebrovascular diseases, such as ischemic stroke (cerebral infarction), coronary heart disease (angina pectoris), and retinal vein occlusion. The drug works by promoting blood circulation, removing blood stasis, and improving microcirculation. Its pharmacological effects include the inhibition of platelet aggregation, reduction of blood viscosity, and protection of vascular endothelial cells. The lyophilized powder formulation is frequently utilized in clinical settings for its enhanced stability and standardized dosing.

Brand names
Xueshuantong
Other names
Xueshuantong Injection (lyophilized)Panax Notoginseng Saponins for InjectionLyophilized Xueshuantong Injection
02

Targets

GPIIb/IIIa (Integrin alpha-IIb/beta-3)F10 (Factor Xa)YWHA (14-3-3 protein family)PIEZO1 (Piezo-type mechanosensitive ion channel component 1)

Beyond the preview

Go deeper on xueshuantong injection.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on xueshuantong injection.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call